OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Guidelines for Prevention and Treatment of Chronic Hepatitis B
Guiqiang Wang, Zhongping Duan
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 76
Guiqiang Wang, Zhongping Duan
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Devin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 10, pp. 879-907
Closed Access | Times Cited: 186
Devin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 10, pp. 879-907
Closed Access | Times Cited: 186
Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China
Xueru Yin, Wei Wang, Hui Chen, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 455-462
Open Access | Times Cited: 19
Xueru Yin, Wei Wang, Hui Chen, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 455-462
Open Access | Times Cited: 19
Is it possible to halve the incidence of liver cancer in China by 2050?
Jufang Shi, Maomao Cao, Yuting Wang, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 5, pp. 1051-1065
Open Access | Times Cited: 132
Jufang Shi, Maomao Cao, Yuting Wang, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 5, pp. 1051-1065
Open Access | Times Cited: 132
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis
Won‐Mook Choi, Terry Cheuk‐Fung Yip, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 534-542
Open Access | Times Cited: 45
Won‐Mook Choi, Terry Cheuk‐Fung Yip, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 534-542
Open Access | Times Cited: 45
Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
Sihui Zhang, Chao Wang, Bei Liu, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 35, pp. 100738-100738
Open Access | Times Cited: 35
Sihui Zhang, Chao Wang, Bei Liu, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 35, pp. 100738-100738
Open Access | Times Cited: 35
A review of epidemiology and clinical relevance of Hepatitis B virus genotypes and subgenotypes
Jing Chen, Li Li, Qi Yin, et al.
Clinics and Research in Hepatology and Gastroenterology (2023) Vol. 47, Iss. 7, pp. 102180-102180
Closed Access | Times Cited: 25
Jing Chen, Li Li, Qi Yin, et al.
Clinics and Research in Hepatology and Gastroenterology (2023) Vol. 47, Iss. 7, pp. 102180-102180
Closed Access | Times Cited: 25
A new approach to prevent, diagnose, and treat hepatitis B in Africa
C. Wendy Spearman, Monique Andersson, Bisi Bright, et al.
BMC Global and Public Health (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 24
C. Wendy Spearman, Monique Andersson, Bisi Bright, et al.
BMC Global and Public Health (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 24
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection
Marion Delphin, Khadija Said Mohammed, Louise Downs, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 4, pp. 383-392
Open Access | Times Cited: 12
Marion Delphin, Khadija Said Mohammed, Louise Downs, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 4, pp. 383-392
Open Access | Times Cited: 12
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Yimin Mao, Shiwu Ma, Chenghai Liu, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 384-419
Closed Access | Times Cited: 12
Yimin Mao, Shiwu Ma, Chenghai Liu, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 384-419
Closed Access | Times Cited: 12
Evaluation of the Potency of Repurposed Antiretrovirals in HBV Therapy: A Narrative Investigation of the Traditional Medicine Alternatives
Samuel Chima Ugbaja, Ata Thabo Mokoena, Aganze Gloire-Aimé Mushebenge, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1523-1523
Open Access | Times Cited: 1
Samuel Chima Ugbaja, Ata Thabo Mokoena, Aganze Gloire-Aimé Mushebenge, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1523-1523
Open Access | Times Cited: 1
Estimating the prevalence of hepatitis B by wastewater-based epidemiology in 19 cities in China
Chenzhi Hou, Zhendong Hua, Peng Xu, et al.
The Science of The Total Environment (2020) Vol. 740, pp. 139696-139696
Closed Access | Times Cited: 54
Chenzhi Hou, Zhendong Hua, Peng Xu, et al.
The Science of The Total Environment (2020) Vol. 740, pp. 139696-139696
Closed Access | Times Cited: 54
One-dimensional screw-like MoS2 with oxygen partially replacing sulfur as an electrocatalyst for the N2 reduction reaction
Xiaoyue Chen, Chaoqun Ma, Zixuan Tan, et al.
Chemical Engineering Journal (2022) Vol. 433, pp. 134504-134504
Closed Access | Times Cited: 37
Xiaoyue Chen, Chaoqun Ma, Zixuan Tan, et al.
Chemical Engineering Journal (2022) Vol. 433, pp. 134504-134504
Closed Access | Times Cited: 37
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao‐Chun Hsu, Cheng‐Hao Tseng, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 869-890
Open Access | Times Cited: 21
Yao‐Chun Hsu, Cheng‐Hao Tseng, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 869-890
Open Access | Times Cited: 21
Viscoelastic parameters derived from multifrequency MR elastography for depicting hepatic fibrosis and inflammation in chronic viral hepatitis
Yikun Wang, Jiahao Zhou, Huimin Lin, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Yikun Wang, Jiahao Zhou, Huimin Lin, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury
Shan Tang, Xiaodan Zhang, Zhongping Duan, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109808-109808
Open Access | Times Cited: 16
Shan Tang, Xiaodan Zhang, Zhongping Duan, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109808-109808
Open Access | Times Cited: 16
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension
Xiaoyuan Xu, Chengwei Tang, Enqiang Linghu, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1565-1579
Open Access | Times Cited: 14
Xiaoyuan Xu, Chengwei Tang, Enqiang Linghu, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1565-1579
Open Access | Times Cited: 14
Prevalence and risk factors of significant Fibrosis in CHB patients with concurrent MASLD
Hong Shan, Yiwei Hao, Lei Sun, et al.
Annals of Hepatology (2024), pp. 101589-101589
Open Access | Times Cited: 5
Hong Shan, Yiwei Hao, Lei Sun, et al.
Annals of Hepatology (2024), pp. 101589-101589
Open Access | Times Cited: 5
Thomas Tu, Thomas McQuaid, Ira M. Jacobson
Liver International (2024) Vol. 45, Iss. 1
Open Access | Times Cited: 5
Global Patterns and Trends in Total Burden of Hepatitis B from 1990 to 2019 and Predictions to 2030
Chi Zhang, Yiqi Liu, Hong Zhao, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1519-1533
Open Access | Times Cited: 19
Chi Zhang, Yiqi Liu, Hong Zhao, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1519-1533
Open Access | Times Cited: 19
Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate
Siying Li, Jie Jin, Yi Jiang, et al.
International Journal of Antimicrobial Agents (2023) Vol. 61, Iss. 3, pp. 106726-106726
Closed Access | Times Cited: 10
Siying Li, Jie Jin, Yi Jiang, et al.
International Journal of Antimicrobial Agents (2023) Vol. 61, Iss. 3, pp. 106726-106726
Closed Access | Times Cited: 10
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Young‐Suk Lim, Henry Lik‐Yuen Chan, Sang Hoon Ahn, et al.
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100847-100847
Open Access | Times Cited: 10
Young‐Suk Lim, Henry Lik‐Yuen Chan, Sang Hoon Ahn, et al.
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100847-100847
Open Access | Times Cited: 10
The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients
Huijun Liang, Haifang Wang, Min-Feng Liang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Huijun Liang, Haifang Wang, Min-Feng Liang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Analysis of Risk Factors for Multidrug-Resistant Bacterial Infection in Patients with Decompensated Cirrhosis
Ling Mao, Honghua Jin, Wenjun Yan, et al.
Jundishapur Journal of Microbiology (2025) Vol. 18, Iss. 3
Open Access
Ling Mao, Honghua Jin, Wenjun Yan, et al.
Jundishapur Journal of Microbiology (2025) Vol. 18, Iss. 3
Open Access
Chemoprevention of Gastrointestinal Cancers: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials and Cohort Studies
Jia En Chan, Suresh Shanmugham, Suresh Kumar, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 5
Open Access
Jia En Chan, Suresh Shanmugham, Suresh Kumar, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 5
Open Access
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
Qian Yang, Hua Ye, Guiying Sun, et al.
Molecular Oncology (2023) Vol. 17, Iss. 5, pp. 887-900
Open Access | Times Cited: 9
Qian Yang, Hua Ye, Guiying Sun, et al.
Molecular Oncology (2023) Vol. 17, Iss. 5, pp. 887-900
Open Access | Times Cited: 9
